Vanderbilt-Ingram Cancer Center Archive — Page 3 of 27

The Vanderbilt Ingram Cancer Center (Neil Brake/Vanderbilt)
September 10, 2025

Vanderbilt-Ingram Cancer Center names associate directors and new program leaders 

Shared resources at Vanderbilt-Ingram are designed to support and enhance cancer-relevant research and scientific interaction by providing access to cutting-edge technologies and services, as well as scientific expertise.

(photo by Erin O. Smith)
September 2, 2025

Vanderbilt-Ingram Cancer Center announces Young Adult Cancer Symposium

The symposium offers clinicians, patients, caregivers and advocates the opportunity to learn from internationally known experts focused on early-onset cancers.

(iStock)
August 28, 2025

Genetic analysis of people with African ancestry reveals lung cancer susceptibilities  

Prior research has shown that Americans of African ancestry have a higher risk of lung cancer compared to white Americans despite smoking fewer cigarettes, but the reasons for this difference are not fully understood.

From left are Susan Morrow Legacy Foundation board members Cam Varner, Gerald Runke, Ron Morrow, Karen Runke, Diana Morrow and Tom McFarlin. (photo by Susan Urmy)
August 19, 2025

Susan Morrow Legacy Foundation supports ovarian cancer research at Vanderbilt

The Susan Morrow Legacy Foundation has made a generous donation to support ovarian cancer research at Vanderbilt University and Vanderbilt University Medical Center.

August 18, 2025

Photos and video from a memorable night: Stand Up to Cancer broadcast highlights Nashville talent, Vanderbilt-Ingram Cancer Center

Viewers saw performances by host Sheryl Crow, as well as the Jonas Brothers, Noah Cyrus, Gavin DeGraw, Marcus King, Brothers Osborne, Jon Pardi, Jelly Roll, Dan + Shay and CeCe Winans.

August 1, 2025

Study reports final clinical trial data for advanced kidney cancer treatment

The drug combo pembrolizumab plus axitinib had sustained and durable clinical benefit in more than five years of follow-up. It is a standard-of-care first-line treatment for advanced kidney cancer.